Structural implications of Siglec-5-mediated sialoglycan recognition
about
Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding siteA structural model for binding of the serine-rich repeat adhesin GspB to host carbohydrate receptorsDetailed insights from microarray and crystallographic studies into carbohydrate recognition by microneme protein 1 (MIC1) ofToxoplasma gondiiStructural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16PILR and PILR have a siglec fold and provide the basis of binding to sialic acidStructural basis for sialic acid-mediated self-recognition by complement factor HSIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomasMultivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase ActivityStructural basis of myelin-associated glycoprotein adhesion and signallingHuman Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrateSiglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.Siglec-mediated regulation of immune cell function in disease.High affinity sialoside ligands of myelin associated glycoprotein.A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D.A Siglec-like sialic-acid-binding motif revealed in an adenovirus capsid proteinSteering Siglec-Sialic Acid Interactions on Living Cells using Bioorthogonal Chemistry.Refolded recombinant Siglec5 for NMR investigation of complex carbohydrate bindingHuman DC-SIGN binds specific human milk glycans.Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsAn expression system for screening of proteins for glycan and protein interactions.Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.Sweet complementarity: the functional pairing of glycans with lectins.Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell FusionStudies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.Structures of the Streptococcus sanguinis SrpA Binding Region with Human Sialoglycans Suggest Features of the Physiological Ligand.Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.Molecular basis of human CD22 function and therapeutic targeting.Novel aspects of sialoglycan recognition by the Siglec-like domains of streptococcal SRR glycoproteins.
P2860
Q24615889-851AA8FA-AA93-4737-97CB-86D097D72854Q27349479-F1A102CA-3A19-4D79-A390-4F94FDE09CC7Q27646533-040B749F-F076-4464-ADA6-63CF15575C42Q27678312-1367DBD0-88F4-4846-B914-472047F1DAD5Q27683849-2576E0E8-9743-46AB-8F91-DF10020F72CDQ27696183-89DBC3DC-7BC2-4762-914A-923B034CD34EQ28237131-74014123-7631-451C-B2FF-38D20B3184B3Q28554453-3A36309C-00D6-4F16-BE7C-67A82F2D8B3CQ28593029-A142826E-947B-4C5C-8B3A-5D56C389B780Q30497345-601668E3-2B43-465F-B8DD-760804C4C98EQ30557434-6ECE1794-D284-48BB-A404-A2922497DEF9Q30829904-48945018-07FA-49DF-BD63-A3D1A0C15B59Q34314957-902F8552-5D12-4C67-9CA5-9967D5466884Q35165362-32953079-0E7B-465C-B7BD-DB9B6D52FD21Q35674073-F5D5BE64-7C43-4F5B-B88D-68845B1A4A94Q36056053-44808DBD-9121-45CB-A298-7789D3809B0CQ36279536-585384FA-DBA4-4330-B6B7-143989CAE398Q36672921-861677A2-6410-4151-9C56-F5AD38B25BD6Q36923732-34B2FCAF-9C1B-4EE1-B1A8-D4FF19CFFF88Q36989586-CC8EB525-3DEB-4045-BE9D-9D82F32F3C0AQ37086947-E3C75197-462F-4B06-B6B2-5A6D50164AC3Q37126813-9B111B39-0078-4A84-BBD5-EBE83B8E09FFQ38598881-961E6AE8-ECAB-416B-967A-E0542BC2EDC2Q38674244-2B44F730-7A98-4678-98AB-E69C60ECD07AQ38766179-4FAE8E05-D68F-4442-A6E5-EB015B0CA878Q38860689-F4209D2D-267E-4695-8D48-F52519A0B540Q39128543-5FCDDE5E-6980-476B-904A-4AD48857176EQ40522700-32AF142C-EA5B-476D-83F2-8EA0A6CA5667Q41200652-D58CDDD2-AC56-4935-BF26-0950B4098F01Q42133647-56751FFB-A760-4DC3-94AF-84D7E8D5FB8FQ42286136-2C0BE1C6-942A-488A-AA15-305791CE98AAQ46969243-642ADB02-1CF6-4B8C-A13E-F17F03E9771F
P2860
Structural implications of Siglec-5-mediated sialoglycan recognition
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Structural implications of Siglec-5-mediated sialoglycan recognition
@ast
Structural implications of Siglec-5-mediated sialoglycan recognition
@en
Structural implications of Siglec-5-mediated sialoglycan recognition
@nl
type
label
Structural implications of Siglec-5-mediated sialoglycan recognition
@ast
Structural implications of Siglec-5-mediated sialoglycan recognition
@en
Structural implications of Siglec-5-mediated sialoglycan recognition
@nl
altLabel
Structural Implications of Siglec-5-Mediated Sialoglycan Recognition
@en
prefLabel
Structural implications of Siglec-5-mediated sialoglycan recognition
@ast
Structural implications of Siglec-5-mediated sialoglycan recognition
@en
Structural implications of Siglec-5-mediated sialoglycan recognition
@nl
P2093
P2860
P1476
Structural implications of Siglec-5-mediated sialoglycan recognition
@en
P2093
Kathryn Trandem
Marina A Zhuravleva
Peter D Sun
P2860
P304
P356
10.1016/J.JMB.2007.10.009
P407
P577
2008-01-11T00:00:00Z